PepGen is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO James G. McArthur, with a market cap of $111.3M.
Common questions about PepGen
PepGen is scheduled to report earnings for Q1 2026 on May 7, 2026.
PepGen has approximately 65 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.